Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Bleomycin

Josiah P. Brandt  1 , Valerie Gerriets  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Bleomycin

Josiah P. Brandt et al.
Free Books & Documents

Excerpt

Bleomycin has approval for adult use in treating squamous cell cancer of head and neck regions, Hodgkin's lymphoma, testicular carcinoma. It is also used as a sclerosing agent for malignant pleural effusions. Off-label use includes treatment of germ cell tumors and pediatric Hodgkin's lymphoma. Bleomycin is in the cytotoxic chemotherapy class of medications. This activity describes the indications, action, and contraindications for bleomycin as a valuable agent in treating various malignant cancers. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the interprofessional team in the treatment of patients with various cancers.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Josiah Brandt declares no relevant financial relationships with ineligible companies.

Disclosure: Valerie Gerriets declares no relevant financial relationships with ineligible companies.

References

    1. Lavoie JM, Kollmannsberger CK. Current Management of Disseminated Germ Cell Tumors. Urol Clin North Am. 2019 Aug;46(3):377-388. - PubMed
    1. Bennett JM, Reich SD. Bleomycin. Ann Intern Med. 1979 Jun;90(6):945-8. - PubMed
    1. Kong J, Yi L, Xiong Y, Huang Y, Yang D, Yan X, Shen B, Duan Y, Zhu X. The discovery and development of microbial bleomycin analogues. Appl Microbiol Biotechnol. 2018 Aug;102(16):6791-6798. - PubMed
    1. Bagheri R, Noori M, Rajayi M, Attaran D, Mohammad Hashem Asna Ashari A, Mohammadzadeh Lari S, Basiri R, Rezaeetalab F, Afghani R, Salehi M. The effect of iodopovidone versus bleomycin in chemical pleurodesis. Asian Cardiovasc Thorac Ann. 2018 Jun;26(5):382-386. - PubMed
    1. Petering DH, Byrnes RW, Antholine WE. The role of redox-active metals in the mechanism of action of bleomycin. Chem Biol Interact. 1990;73(2-3):133-82. - PubMed

Publication types

LinkOut - more resources